Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Anita S. Kablinger"'
Autor:
Ching-Fang Sun, Akhil S. Pola, Kuan-Pin Su, Binx Y. Lin, Anita S. Kablinger, Robert L. Trestman
Publikováno v:
Drug and Alcohol Dependence Reports, Vol 12, Iss , Pp 100270- (2024)
Background: Benzodiazepines (BZDs) are widely prescribed for anxiety disorders. However, the long-term implications on mental health remain uncertain, especially the potential association between chronic BZD use and subsequent diagnosis of mood and s
Externí odkaz:
https://doaj.org/article/e107fa2b29664605b82390ce7c31d502
Autor:
Charles R. Conway, Scott T. Aaronson, Harold A. Sackeim, Walter Duffy, Mary Stedman, João Quevedo, Rebecca M. Allen, Patricio Riva-Posse, Matthew A. Berger, Gustavo Alva, Mohd Azfar Malik, David L. Dunner, Ivan Cichowicz, Heather Luing, John Zajecka, Ziad Nahas, Brian J. Mickey, Anita S. Kablinger, Christopher L. Kriedt, Mark T. Bunker, Ying-Chieh (Lisa) Lee, Olivia Shy, Shannon Majewski, Bryan Olin, Quyen Tran, A. John Rush
Publikováno v:
Brain Stimulation, Vol 17, Iss 2, Pp 448-459 (2024)
Background: RECOVER is a randomized sham-controlled trial of vagus nerve stimulation and the largest such trial conducted with a psychiatric neuromodulation intervention. Objective: To describe pre-implantation baseline clinical characteristics and t
Externí odkaz:
https://doaj.org/article/156dd0d5a57c406682850a3080a126e8
Autor:
Fatima Quddos, Zachary Hubshman, Allison Tegge, Daniel Sane, Erin Marti, Anita S. Kablinger, Kirstin M. Gatchalian, Amber L. Kelly, Alexandra G. DiFeliceantonio, Warren K. Bickel
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Alcohol Use Disorder (AUD) contributes significantly to global mortality. GLP-1 (Glucagon-like peptide-1) and GLP-1/GIP (Glucose-dependent Insulinotropic Polypeptide) agonists, FDA-approved for managing type 2 diabetes and obesity, where the
Externí odkaz:
https://doaj.org/article/c7be5a81d29d44189822aa8ee3929127
Autor:
Ilan A. Kerman, Matthew E. Glover, Yezhe Lin, Jennifer L. West, Alexandra L. Hanlon, Anita S. Kablinger, Sarah M. Clinton
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2024)
Objective: This study sought to investigate the relationship between antibiotic exposure and subsequent risk of psychiatric disorders.Methods: This retrospective cohort study used a national database of 69 million patients from 54 large healthcare or
Externí odkaz:
https://doaj.org/article/15f0cc8a6ff24440ab0882b87147f246
Autor:
Hayoung Ko, Alyssa J. Gatto, Sydney B. Jones, Virginia C. O’Brien, Robert S. McNamara, Martha M. Tenzer, Hunter D. Sharp, Anita S. Kablinger, Lee D. Cooper
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Background Measurement-Based Care (MBC) is an evidence-based practice shown to enhance patient care. Despite being efficacious, MBC is not commonly used in practice. While barriers and facilitators of MBC implementation have been described i
Externí odkaz:
https://doaj.org/article/078b5914843743288f7edd59165ca390
Autor:
Rakesh Kumar, MD, Aysegul Aydogan, MD, Anand Singh, MBBS, Anita S. Kablinger, MD, Sandeep R. Pagali, MDMPH
Publikováno v:
Brain Stimulation, Vol 16, Iss 4, Pp 9- (2023)
Externí odkaz:
https://doaj.org/article/21cadf0d8ac3451a820bb07e319220de
Publikováno v:
Case Reports in Psychiatry, Vol 2023 (2023)
Venlafaxine is an antidepressant belonging to the class of serotonin–norepinephrine reuptake inhibitors that are US Food and Drug Administration-approved to treat and manage symptoms of depression, anxiety, and other mood disorders in adults. We de
Externí odkaz:
https://doaj.org/article/f084ed0c8c6a4cac855ace624fd5bbba
Publikováno v:
Case Reports in Psychiatry, Vol 2023 (2023)
Schizoaffective disorder is categorized by major mood episodes and symptoms of schizophrenia that include disorganized speech, delusions, paranoia, and hallucinations. It is associated with risk factors, including a history of abuse and cannabis use,
Externí odkaz:
https://doaj.org/article/2ee8a9754d634543a379db8f0a6a21b9
Autor:
Albert Yi-Que Truong, Brian Fabian Saway, Malek H. Bouzaher, Mustafa Nawroz Rasheed, Sanaz Monjazeb, Soleille Dorothy Everest, Susan Linda Giampalmo, David Hartman, Cheryl Hartman, Anita S. Kablinger, Robert L. Trestman
Publikováno v:
BMC Psychiatry, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background Clinical trials provide consistent evidence for buprenorphine’s efficacy in treating opioid use disorder (OUD). While the Drug Addiction Treatment Act of 2000 requires physicians to combine medication-assisted treatment (MAT) wi
Externí odkaz:
https://doaj.org/article/f0a22d266ecc4850ac5c93a0393d5298
Autor:
Hailey L. Gosnell, Anita S. Kablinger
Publikováno v:
Case Reports in Psychiatry, Vol 2020 (2020)
Obsessive-compulsive disorder (OCD), a relatively common psychiatric illness, is diagnosed using DSM-V criteria. Its severity is assessed using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). Symptoms are broken down into five categories of obses
Externí odkaz:
https://doaj.org/article/54307a55c63c4c6bbd105e60093485fc